Connect with us

Hi, what are you looking for?

Captain Of Success
Top Stories

Stock Markets

‘Side effect’ label on meds urged

PHILSTAR FILE PHOTO

THE Food and Drug Administration (FDA) should mandate drug companies to plaster warnings informing of possible side effects on the medical products they sell, a congressman said on Sunday.

“If cigarettes… have such labels, then it is only right that all medicinal products, especially those we ingest or inject into our bodies, should also have warning labels about adverse side effects,” Surigao del Norte Rep. Robert Ace S. Barbers said in a statement.

He said he’s willing to draft a bill requiring drug manufacturers to affix side effect warnings on medicines if the FDA has no compelling authority over them.

Mr. Barbers’ call for transparency about possible adverse medical events comes after he received concerns that prolonged use of some maintenance medication has led to further illness. — Kenneth Christiane L. Basilio

    You May Also Like

    Stock Markets

    Students of the Institute of Civil Engineering of the University of the Philippines Diliman experience what it’s like on-board the Circular Explorer and attend...

    Stock Markets

    BW FILE PHOTO THE NATIONAL Government’s (NG) debt service bill surged year on year in November as both interest and amortization payments rose, data...

    Stock Markets

    In the photo are (seated L to R) Francisco “Coco” D.C. Mauricio, WeFund Lending Corp. President and CEO; Danilo “Bong” J. Mojica II, UnionDigital...

    Stock Markets

    THE DEVELOPMENT Bank of the Philippines (DBP) will again request for regulatory relief this year as it seeks to boost its capital position. “Just...

    Disclaimer: CaptainOfSuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
    The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.